Swiss company Qnami, a leader in quantum sensing technology, tasked us with identifying potential applications in the biomedical area where NV magnetometry could provide clinical value and open new commercial avenues.
The proposal estimates compliance costs at €29 billion but could provide cyber-clarity.
Lizzie Thomas presents her case for designing improved, sustainable drug delivery product design. Currently, the approach is dominated at the outset by patient-centricity. This focus means that wider, more long-term implications simply aren’t considered early enough.
Rodney Richardson, software and systems engineer, who has spent the past 20 years designing and developing medical software, outlines ten essential points for medical device developers regarding cybersecurity.
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong.